Glowing terms often used for new cancer drugs in health news Health news stories often use overly optimistic terms to describe new cancer drugs, according to a new study.
British cancer drugs fund changes tack: again A British cancer drugs scheme, slammed as "stupid" by Roche's chief executive two months ago, has undergone another about-turn, with some medicines dropped from coverage now being reinstated.
Mixed message on weed-killer reflects reality of scientific uncertainty Contradictory advice from two European-based agencies about the cancer risk posed by the weed-killer glyphosate offers clarity on only one message: that uncertainty is inherent in the scientific process.
Less prostate cancer and screening seen after new guidance Far fewer U.S. men are being diagnosed with early-stage prostate cancer and getting blood tests to detect the disease since an influential government-appointed panel recommended against routine screening of all men, an American Cancer Society study found.
Patriots lineman Nate Solder says infant son has cancer New England Patriots offensive lineman Nate Solder has disclosed that his infant son has cancer.
Roche breast cancer drug at center of UK pricing row A Roche drug that can prolong the lives of some women with advanced breast cancer has been plunged back into the center of a drug pricing row after Britain's health cost agency declared that it is still too expensive.
FDA approves J&J drug for advanced multiple myeloma U.S. regulators have approved an experimental treatment from Johnson & Johnson that may offer hope to multiple myeloma patients who have run out of other options against the blood cancer.
Boston woman with terminal illness runs her last marathon Kim Stemple didn't want this story to be about her.
Choice in colon cancer screening linked to more regular testing People may be more likely to get colorectal cancer screenings when doctors let them choose what type of test to have, a U.S. study suggests.
Women panic less when abnormal breast cells are not called cancer Women may be less likely to panic or pursue aggressive treatment for a common, non-invasive breast tumor if doctors don't use the word "cancer" to describe the abnormal cells, an Australian study suggests.
